Hepatitis C

被引：14
|
作者：
Jenny-Avital, ER [1 ]
机构：
[1] Jacobi Med Ctr, Bronx, NY 10461 USA
来源：
CURRENT OPINION IN INFECTIOUS DISEASES | 1998年 / 11卷 / 03期
关键词：
D O I：
10.1097/00001432-199806000-00005
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Hepatitis C virus commonly causes chronic liver disease. Chronicity as a result of the failure of T-cell-mediated immunity, liver damage caused by cytotoxic T lymphocytes, and the evolution of genetic diversity characterize hepatitis C infection. Progression, typically silent, is determined by sex, age, alcohol and immune status. Interferon and ribavirin are effective in the substantial minority of patients with less advanced fibrosis and lower hepatitis C viral loads. (C) 1998 Lippincott-Raven Publishers.
引用
收藏
页码：293 / 299
页数：7
相关论文
共 50 条
  • [1] Hepatitis C Hepatitis C: extrahepatic Manifestations
    Ruchalla, Elke
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2016, 54 (09):
  • [2] Treatment of hepatitis C [Therapie der Hepatitis C]
    Schneider M.D.
    Kronenberger B.
    Zeuzem S.
    Sarrazin C.
    Der Internist, 2015, 56 (4): : 391 - 405
  • [3] Hepatitis C — Update 2015Hepatitis C
    Johannes Weiß
    Andreas Geier
    MMW - Fortschritte der Medizin, 2015, 157 (Suppl 3) : 86 - 93
  • [4] Hepatitis C
    Chan, Juliana
    DM DISEASE-A-MONTH, 2014, 60 (05): : 201 - 212
  • [5] Hepatitis C
    Ursula Weiss
    Nature, 2005, 436 : 929 - 929
  • [6] HEPATITIS C
    Brody, Herb
    NATURE, 2011, 474 (7350) : CP17 - CP17
  • [7] On hepatitis C
    不详
    ISRAEL JOURNAL OF MEDICAL SCIENCES, 1997, 33 (04): : 289 - 290
  • [8] Hepatitis C
    Di Bisceglie, AM
    LANCET, 1998, 351 (9099): : 351 - 355
  • [9] Hepatitis C
    Jadoul, M
    LANCET, 1998, 351 (9110): : 1209 - 1209
  • [10] Hepatitis C
    Coates, S
    Choo, QL
    Kuo, G
    Crawford, K
    Dong, C
    Wininger, M
    Weiner, A
    Abrignani, S
    Houghton, M
    VACCINES: PREVENTING DISEASE AND PROTECTING HEALTH, 2004, (596): : 150 - 156
12345